Related references
Note: Only part of the references are listed.Investigation of immunogenic effect of the BCG priming and Ag85A-GM-CSF boosting in Balb/c mice model
Jun Dou et al.
IMMUNOBIOLOGY (2010)
Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime-boost regimen
Yasir A. W. Skeiky et al.
VACCINE (2010)
Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Mycobacterium tuberculosis-infected Individuals
Clare R. Sander et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Immunogenicity and Protective Efficacy of Prime-Boost Regimens with Recombinant ΔureC hly+ Mycobacterium bovis BCG and Modified Vaccinia Virus Ankara Expressing M-tuberculosis Antigen 85A against Murine Tuberculosis
Elma Z. Tchilian et al.
INFECTION AND IMMUNITY (2009)
Extensively drug-resistant tuberculosis
Mandeep Jassal et al.
LANCET INFECTIOUS DISEASES (2009)
Evaluation of a recombinant BCG expressing antigen Ag85B and PPE protein Rv3425 from DNA segment RD11 of Mycobacterium tuberculosis in C57BL/6 mice
Jiu Ling Wang et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2009)
Subcutaneous boosting with heparin binding haemagglutinin increases BCG-induced protection against tuberculosis
Carine Rouanet et al.
MICROBES AND INFECTION (2009)
Intranasal Mucosal Boosting with an Adenovirus-Vectored Vaccine Markedly Enhances the Protection of BCG-Primed Guinea Pigs against Pulmonary Tuberculosis
Zhou Xing et al.
PLOS ONE (2009)
Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
Kathryn T. Whelan et al.
PLOS ONE (2009)
MVA.85A Boosting of BCG and an Attenuated, phoP Deficient M. tuberculosis Vaccine Both Show Protective Efficacy Against Tuberculosis in Rhesus Macaques
Frank A. W. Verreck et al.
PLOS ONE (2009)
Genomic Diversity among Drug Sensitive and Multidrug Resistant Isolates of Mycobacterium tuberculosis with Identical DNA Fingerprints
Stefan Niemann et al.
PLOS ONE (2009)
Immunological Memory Transferred with CD4 T Cells Specific for Tuberculosis Antigens Ag85B-TB10.4: Persisting Antigen Enhances Protection
Darragh Duffy et al.
PLOS ONE (2009)
Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys
Steven G. Reed et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Protective efficacy of recombinant BCG Tokyo (Ag85A) in rhesus monkeys (Macaca mulatta) infected intratracheally with H37Rv Mycobacterium tuberculosis
I. Sugawara et al.
TUBERCULOSIS (2009)
Fusion protein Ag85B-MPT64190-198-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice
Yu Luo et al.
VACCINE (2009)
Neonatal vaccination with Mycobacterium bovis BCG: Potential effects as a priming agent shown in a heterologous prime-boost immunization protocol
Muhammad Jubayer Rahman et al.
VACCINE (2009)
Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis
Ronggai Sun et al.
VACCINE (2009)
Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primates
Michelle H. Larsen et al.
VACCINE (2009)
What Animal Models Teach Humans about Tuberculosis
Ashwin S. Dharmadhikari et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)
A Replication-Limited Recombinant Mycobacterium bovis BCG Vaccine against Tuberculosis Designed for Human Immunodeficiency Virus-Positive Persons Is Safer and More Efficacious than BCG
Michael V. Tullius et al.
INFECTION AND IMMUNITY (2008)
Efficacy of recombinant bacille Calmette-Guerin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis
Ce Tang et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
A New Recombinant Bacille Calmette-Guerin Vaccine Safely Induces Significantly Enhanced Tuberculosis-Specific Immunity in Human Volunteers
Daniel F. Hoft et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa
Tony Hawkridge et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa
Roger H. Brookes et al.
PLOS ONE (2008)
Enhanced and Enduring Protection against Tuberculosis by Recombinant BCG-Ag85C and Its Association with Modulation of Cytokine Profile in Lung
Ruchi Jain et al.
PLOS ONE (2008)
rBCG Induces Strong Antigen-Specific T Cell Responses in Rhesus Macaques in a Prime-Boost Setting with an Adenovirus 35 Tuberculosis Vaccine Vector
Isabelle Magalhaes et al.
PLOS ONE (2008)
Evaluation of a new recombinant BCG which contains mycobacterial antigen ag85B-mpt64190-198-mtb8.4 in C57/BL6 mice
Y. Q. Qie et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2008)
The clinical consequences of strain diversity in Mycobacterium tuberculosis
Mark P. Nicol et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2008)
Recombinant BCG coexpressing Ag85B, ESAT-6 and mouse-IFN-γ confers effective protection against Mycobacterium tuberculosis in C57BL/6 mice
Ying Xu et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2007)
Recombinant BCG Tokyo (Ag85A) protects cynomolgus monkeys (Macaca fascicularis) infected with H37Rv Mycobacterium tuberculosis
I. Sugawara et al.
TUBERCULOSIS (2007)
Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials
Ansar A. Pathan et al.
PLOS ONE (2007)
Heparin-Binding-Hemagglutinin-Induced IFN-γ Release as a Diagnostic Tool for Latent Tuberculosis
Jean-Michel Hougardy et al.
PLOS ONE (2007)
Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon
Katarina Radosevic et al.
INFECTION AND IMMUNITY (2007)
Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A
I. Sugawara et al.
TUBERCULOSIS (2007)
Worldwide emergence of extensively drug-resistant tuberculosis
N. Sarita Shah et al.
EMERGING INFECTIOUS DISEASES (2007)
Immunological responses and protective immunity against tuberculosis conferred by vaccination of Balb/C mice with the attenuated Mycobacterium tuberculosis (phoP) SO2 strain
D. Aguilar et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Mycobacterium tuberculosis ΔRD1 ΔpanCD:: A safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis
Vasan K. Sambandamurthy et al.
VACCINE (2006)
Global incidence of multidrug-resistant tuberculosis
Matteo Zignol et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobactetium bovis BCG immunization against pulmonary tuberculosis
Michael Santosuosso et al.
INFECTION AND IMMUNITY (2006)
Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunization
Zhou Xing et al.
TUBERCULOSIS (2006)
Heparin-binding hemagglutinin, from an extrapulmonary dissemination factor to a powerful diagnostic and protective antigen against tuberculosis
Camille Locht et al.
TUBERCULOSIS (2006)
The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs
C Martin et al.
VACCINE (2006)
Effect of BCG vaccination on childhood tuberculous meningitis and miliarytuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness
BB Trunz et al.
LANCET (2006)
Extraordinarily few organisms of a live recombinant BCG vaccine against tuberculosis induce maximal cell-mediated and protective immunity
MA Horwitz et al.
VACCINE (2006)
Decreased survival of guinea pigs infected with Mycobacterium tuberculosis after multiple BCG vaccinations
RJ Basaraba et al.
VACCINE (2006)
Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial
LC Rodrigues et al.
LANCET (2005)
Recent advances in the development of adenovirus- and poxvirus-vectored tuberculosis vaccines
Z Xing et al.
CURRENT GENE THERAPY (2005)
Tuberculosis control in the era of HIV
P Nunn et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin
L Grode et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Effector functions of heparin-binding hemagglutinin-specific CD8+ T lymphocytes in latent human tuberculosis
ST Temmerman et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in guinea pigs
A Williams et al.
INFECTION AND IMMUNITY (2005)
The use of animal models to guide rational vaccine design
IA Orme
MICROBES AND INFECTION (2005)
Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6
JAM Langermans et al.
VACCINE (2005)
Expanding the antigenic repertoire of BCG improves protective efficacy against aerosol Mycobacterium tuberculosis infection
U Palendira et al.
VACCINE (2005)
Long-term protection against tuberculosis following vaccination with a severely attenuated double lysine and pantothenate auxotroph of Mycobacterium tuberculosis
VK Sambandamurthy et al.
INFECTION AND IMMUNITY (2005)
Evaluation of vaccines in the EU TB vaccine cluster using a guinea pig aerosol infection model of tuberculosis
A Williams et al.
TUBERCULOSIS (2005)
Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin
S Temmerman et al.
NATURE MEDICINE (2004)
A polyvalent DNA vaccine expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity
SC Derrick et al.
VACCINE (2004)
Comparative analysis of different vaccine constructs expressing defined antigens from Mycobacterium tuberculosis
TM Doherty et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
The mycobacterial heparin-binding hemagglutinin is a protective antigen in the mouse aerosol challenge model of tuberculosis
M Parra et al.
INFECTION AND IMMUNITY (2004)
The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M-tuberculosis-infected guinea pigs
L Brandt et al.
INFECTION AND IMMUNITY (2004)
Application of mycobacterial proteomics to vaccine design:: Improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis
HJ Mollenkopf et al.
INFECTION AND IMMUNITY (2004)
Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans
H McShane et al.
NATURE MEDICINE (2004)
Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model
AW Olsen et al.
INFECTION AND IMMUNITY (2004)
Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination
BM Buddle et al.
INFECTION AND IMMUNITY (2003)
Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans
SJ McConkey et al.
NATURE MEDICINE (2003)
Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis
AS Pym et al.
NATURE MEDICINE (2003)
A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis
MA Horwitz et al.
INFECTION AND IMMUNITY (2003)
Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti
AS Pym et al.
MOLECULAR MICROBIOLOGY (2002)
Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene family
RLV Skjot et al.
INFECTION AND IMMUNITY (2002)
Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosis
TM Doherty et al.
INFECTION AND IMMUNITY (2002)
Differential T and B cell responses against Mycobacterium tuberculosis heparin-binding hemagglutinin adhesin in infected healthy individuals and patients with tuberculosis
C Masungi et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Failure of the Mycobacterium bovis BCG vaccine:: Some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis
L Brandt et al.
INFECTION AND IMMUNITY (2002)
The heparin-binding haemagglutinin of M-tuberculosis is required for extrapulmonary dissemination
K Pethe et al.
NATURE (2001)
Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85B and ESAT-6
AW Olsen et al.
INFECTION AND IMMUNITY (2001)
Recombinant bacillus Calmette-Guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model
MA Horwitz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
